drugset / Trial / NCT03295656

Contrast-Enhanced Ultrasound Diagnosis of Acute Appendicitis

NCT03295656

Phase 1 Withdrawn Boston Children's Hospital
NaSingle-groupOpen-labelDiagnostic

Summary

This study evaluates the ability of contrast-enhanced ultrasound to improve the diagnosis of acute appendicitis in children compared to conventional ultrasound.

Timeline

Start
2020-07-15
Primary completion
2020-07-15
Completion
2020-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Lumason Diagnostic / imaging agent 0.03 unknown Intravenous

Indications